The Nanomedicine Living Lab is a collaboration platform between Radboud University, Radboudumc, and five private parties. It is a direct result from an outreach initiative of the Nanomedicine theme. Together these partners organize a setting that facilitates the entire drug development chain. The Living Lab is a facility that provides access to the whole spectrum of state-of-the-art technologies relating to nanomedicine. Thus, the living lab will stimulate innovation at the intersection of drug development and nanotechnology. Seven public and private parties will bring their facilities and expertise to the Nanomedicine Living Lab: Radboud University, Radboudumc, FutureChemistry, Mercurna, Cytofind Diagnostics, In Situ Insights, and Pharmacytics. This regional network will continue to expand throughout the duration of the project and parties from outside the consortium can also use this living lab. The living lab also aims to establish a wide network for sharing knowledge and expertise in the eastern part of the Netherlands. The project is made possible in part by financial support from the European Regional Development Fund (ERDF). It is led by Rutjes (Synthetic Organic Chemistry, IMM) and Wilson (Systems Chemistry, IMM).